![Cover image for Adverse events and oncotargeted kinase inhibitors Cover image for Adverse events and oncotargeted kinase inhibitors](/client/assets/5.0.0.9/ctx//client/images/no_image.png)
Title:
Adverse events and oncotargeted kinase inhibitors
Author:
Tridente, G., author.
ISBN:
9780128094457
Physical Description:
1 online resource
General Note:
Part I: General Aspects 1. Introduction 2. Protein and Lipid Kinases 3. Kinase Inhibitors 4. Adverse Events Part II: Oncotargeted Kinase Inhibitors 5. Imatinib 6. Gefitinib 7. Erlotinib 8. Sorafenib 9. Sunitinib 10. Dasatinib 11. Lapatinib 12. Nilotinib 13. Pazopanib 14. Vandetanib 15. Vemurafenib 16. Crizotinib 17. Ruxolitinib 18. Axitinib 19. Bosutinib 20. Regorafenib 21. Cabozantinib 22. Ponatinib 23. Dabrafenib 24. Trametinib 25. Adatinib 26. Idelalisib 27. Ibrutinib Part III: Overview 28. Kinase Inhibitors as Adverse Event Inducers 29. Kinase Inhibitors as Drug Class Events 30. Conclusion and Perspectives.
Electronic Access:
ScienceDirect http://www.sciencedirect.com/science/book/9780128094006Copies:
Available:*
Library | Material Type | Item Barcode | Shelf Number | Status | Item Holds |
---|---|---|---|---|---|
Searching... | E-Book | 459505-1001 | ONLINE | Searching... | Searching... |